关键词: Kondo-Fu type MBTPS1 genotype phenotype rhGH therapy spondyloepiphyseal dysplasia

来  源:   DOI:10.3389/fped.2023.1068718   PDF(Pubmed)

Abstract:
UNASSIGNED: Variants in membrane-bound transcription factor peptidase, site 1 (MBTPS1) gene, can result in clinically rare spondyloepiphyseal dysplasia of Kondo-fu type (OMIM #618392, SEDKF), Silver-Russell syndrome, and CAOP (cataract, alopecia, oral mucosal disorder, and psoriasis-like) syndrome.
UNASSIGNED: A 6-year-old Chinese male child diagnosed with SEDKF underwent 3 years of growth hormone therapy. A genetic examination revealed two new nonsense variants in the MBTPS1 gene on chromosome 16q23-q24 with compound heterozygotes c.1589(exon12)A > G and c.163(exon2)G > A.
UNASSIGNED: The MBTPS1 gene c.1589(exon12)A > G and c.163(exon2)G > A on chromosome 16q23-q24 is associated with SEDKF. Growth hormone therapy can repair growth retardation in patients with spondyloepiphyseal dysplasia, Kondo-Fu type; however, more evidence of such patient cases is required to support this hypothesis.
摘要:
未经证实:膜结合转录因子肽酶的变体,位点1(MBTPS1)基因,可导致临床上罕见的Kondo-fu型脊柱骨骨发育不良(OMIM#618392,SEDKF),Silver-Russell综合征,和CAOP(白内障,脱发,口腔粘膜疾病,和牛皮癣样)综合征。
未经证实:一名被诊断患有SEDKF的6岁中国男性儿童接受了3年的生长激素治疗。遗传检查发现,染色体16q23-q24上的MBTPS1基因中有两个新的无义变体,具有复合杂合子c.1589(exon12)A>G和c.163(exon2)G>A。
未经证实:染色体16q23-q24上的MBTPS1基因c.1589(exon12)A>G和c.163(exon2)G>A与SEDKF相关。生长激素治疗可以修复脊椎骨发育不良患者的生长迟缓,Kondo-Fu类型;然而,这类病例需要更多的证据来支持这一假设.
公众号